首页|心房颤动及心房扑动智能评分系统在门诊的应用情况及来诊患者特点

心房颤动及心房扑动智能评分系统在门诊的应用情况及来诊患者特点

扫码查看
目的:评价心房颤动及心房扑动智能评分系统在门诊的应用情况及来诊患者特点.方法:收集 2020 年 8 月至 2022 年 6 月于中国医学科学院阜外医院门诊就诊的 25 223 例心房颤动及心房扑动患者的所有就诊记录.比较系统更新(2021 年 9 月)前后来诊患者的特点.另从 25 223 例患者中筛选出系统更新前后 1年内相邻 2 次就诊的患者 404 例,比较 2 次评分的变化趋势及抗凝药物使用情况.结果:与系统更新前比,系统更新后CHA2DS2-VASc评分中男性≥2 分或女性≥3 分的患者比例差异无统计学意义(P>0.05),这些患者中抗凝治疗比例升高(25.2%vs.35.9%,P<0.001).无不评分理由患者比例系统更新前为37.9%,更新后下降至 21.2%.比较 404 例系统更新前后 1 年内相邻 2 次就诊记录发现,与更新前比,更新后患者的CHA2DS2-VASc评分升高[(2.12±1.48)分 vs.(2.35±1.51)分,P=0.029],同时CHA2DS2-VASc评分中男性≥2 分或女性≥3 分的患者比例升高(49.5%vs.58.7%,P=0.011),这些患者中抗凝治疗比例也升高(28.5%vs.41.4%,P<0.001).HAS-BLED评分及HAS-BLED评分≥3 分患者的比例在系统更新前后差异均无统计学意义(P均>0.05).结论:本院门诊所应用的智能评分系统可有效帮助医生掌握来诊心房颤动及心房扑动患者的血栓栓塞和出血风险及相应的变化趋势,并帮助改善抗凝药物的使用.但还需进一步优化评分流程,规范患者评估及治疗.
Impact of the Intelligent Scoring System Use on Clinical Practice of Outpatients With Atrial Fibrillation and Atrial Flutter and Patients Characteristics Analysis
Objectives:To assess the application effectiveness of the intelligent atrial fibrillation/flutter scoring system in the outpatient department and analyze the characteristics of patients diagnosed with atrial fibrillation/flutter.Methods:Medical records of 25 223 patients with atrial fibrillation and atrial flutter,who visited our outpatient department from August 2020 to June 2022,were collected.Characteristics of patients visited before and after the system update(September 2021)were compared.Then,404 patients,with scoring before and after system update within one year period,were selected for analysis,and the study compared the trend of score changes and the utilization of anticoagulants among these patients.Results:There was no significant change in the proportion of patients with a CHA2DS2-VASc score of male≥2 points or female≥3 points before and after the system update.However,the percentage of patients who received anticoagulation treatment increased post system update compared to the pre-update period(35.9%vs.25.2%,P<0.001).The proportion of patients who did not receive a score without any specified reason for not scoring decreased after the system update(21.2%vs.37.9%,P<0.001).For the 404 patients,who visited our outpatient department twice before and after the system update,it was observed that the CHA2DS2-VASc score exhibited an upward trend(2.12±1.48 vs.2.35±1.51,P=0.029).Concurrently,there was an increase in the proportion of patients with a high thrombosis risk(58.7%vs.49.5%,P=0.011),and a rise in the proportion of patients receiving anticoagulant treatment(41.4%vs.28.5%,P<0.001).There was no significant change in the HAS-BLED score and the proportion of patients with a HAS-BLED score of≥3 points(both P>0.05).Conclusions:The intelligent scoring system implemented in our outpatient department effectively helps doctors grasp the risk of thromboembolism and bleeding in patients with atrial fibrillation/flutter,and aids in improving the use of anticoagulants.Further optimization of the scoring process and standardization of patient evaluation and treatment are needed.

outpatient serviceCHA2DS2-VASc scoreHAS-BLED scoreelectronic health records

孙一博、张博、于飞、杨晴、杨国胜、丁立刚、窦克非、朱俊、梁岩

展开 >

中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院 内科重症病区,北京 100037

中国医学科学院 北京协和医学院国家心血管病中心 阜外医院 信息中心,北京 100037

中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院 门诊部,北京 100037

中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院 心律失常中心,北京 100037

中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院 内科管委会,北京 100037

中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院 急诊中心,北京 100037

展开 >

门诊 CHA2DS2-VASc评分 HAS-BLED评分 电子健康记录

2024

中国循环杂志
中国医学科学院

中国循环杂志

CSTPCD北大核心
影响因子:2.803
ISSN:1000-3614
年,卷(期):2024.39(4)
  • 22